Interferon therapy for prevention of hepatocellular cancer in patients with HCV related cirrhosis: A meta-analysis.

被引:0
|
作者
Papadimitropoulos, V [1 ]
Papatheodoridis, GV [1 ]
Hadziyannis, SJ [1 ]
机构
[1] Hippokratio Gen Hosp, Athens, Greece
关键词
D O I
10.1016/S0016-5085(00)81815-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
6694
引用
收藏
页码:A1478 / A1478
页数:1
相关论文
共 50 条
  • [1] Interferon for prevention of hepatocellular carcinoma in patients with hepatitis C virus related cirrhosis: A meta-analysis.
    Papadimitropoulos, V
    Papatheodoridis, GV
    Hadziyannis, SJ
    [J]. HEPATOLOGY, 2000, 32 (04) : 569A - 569A
  • [2] Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis.
    Papatheodoridis, GV
    Papadimitropoulos, VC
    Hadziyannis, SJ
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (05) : 689 - 698
  • [3] Interferon and interferon plus ribavirine in hepatocellular carcinoma prevention: A prospective study on patients with HCV related cirrhosis
    Azzaroli, F
    Mazzella, G
    Accogli, E
    Giovanelli, S
    Trere, D
    Mazzeo, C
    Nigro, G
    Miracolo, A
    Lodato, F
    Colecchia, A
    Mwangemi, C
    Festi, D
    Derenzini, M
    Roda, E
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A703 - A703
  • [4] Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: A prospective study on patients with HCV related cirrhosis
    Francesco, Azzaroli
    Esterita, Accogli
    Giovanni, Nigro
    Davide, Trere
    Silvia, Giovanelli
    Anna, Miracolo
    Francesca, Lodato
    Marco, Montagnani
    Mariarosa, Tame
    Antonio, Colecchia
    Constance, Mwangemi
    Davide, Festi
    Enrico, Roda
    Massimo, Derenzini
    Giuseppe, Mazzella
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (21) : 3099 - 3102
  • [5] Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: A prospective study on patients with HCV related cirrhosis
    Francesco Azzaroli
    Esterita Accogli
    Giovanni Nigro
    Davide Trerè
    Silvia Giovanelli
    Anna Miracolo
    Francesca Lodato
    Marco Montagnani
    Mariarosa Tamé
    Antonio Cloecchia
    Constance Mwangemi
    Davide Festi
    Enrico Roda
    Massimo Derenzini
    Giuseppe Mazzella
    [J]. World Journal of Gastroenterology, 2004, (21) : 3099 - 3102
  • [6] Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis
    Testino, G
    Ansaldi, F
    Andorno, E
    Ravetti, GL
    Ferro, C
    De Iaco, F
    Icardi, G
    Valente, U
    [J]. HEPATO-GASTROENTEROLOGY, 2002, 49 (48) : 1636 - 1638
  • [7] HCC IN PATIENTS WITH HCV CIRRHOSIS AND SUSTAINED VIROLOGICAL RESPONSE WITH INTERFERON AND RIBAVIRIN THERAPY- A META-ANALYSIS
    Jaganmohan, Sathya
    Guturu, Praveen
    Malhotra, Advitya
    Sood, Gagan K.
    [J]. HEPATOLOGY, 2008, 48 (04) : 948A - 948A
  • [8] Effects of interferon therapy on development of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis: A meta-analysis of randomized controlled trials
    Qu, Li-Shuai
    Chen, Hong
    Kuai, Xiao-Ling
    Xu, Zheng-Fu
    Jin, Fei
    Zhou, Guo-Xiong
    [J]. HEPATOLOGY RESEARCH, 2012, 42 (08) : 782 - 789
  • [9] OUTCOMES OF INTERFERON-FREE DIRECT ACTING ANTIVIRAL THERAPY IN PATIENTS WITH HCV-RELATED DECOMPENSATED CIRRHOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Jongraksak, Tanawat
    Chuncharunee, Alan
    Intaraprasong, Pongphob
    Tansawat, Amarit
    Thakkinstian, Ammarin
    Sobhonslidsuk, Abhasnee
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S1153 - S1154
  • [10] Hepatocellular carcinoma and interferon therapy in HCV compensated cirrhosis: Evaluation in relation to virological response
    Testino, G
    Icardi, G
    [J]. HEPATO-GASTROENTEROLOGY, 2005, 52 (63)